Localized Delivery of shRNA against PHD2 Protects the Heart from Acute Myocardial Infarction through Ultrasound-Targeted Cationic Microbubble Destruction.
Localized Delivery of shRNA against PHD2 Protects the Heart from Acute Myocardial Infarction through Ultrasound-Targeted Cationic Microbubble Destruction.
复制标题
针对 PHD2 的 shRNA 局部递送可通过超声靶向阳离子微泡破坏来保护心脏免受急性心肌梗死的侵害。
作者:
Zhang L;Sun Z;Ren P;You M;Zhang J;Fang L;Wang J;Chen Y;Yan F;Zheng H;Xie M
Hypoxia-inducible factor 1α (HIF-1α) plays a critical protective role in ischemic heart disease. Under normoxic conditions, HIF-1α was degraded by oxygen-dependent prolyl hydroxylase-2 (PHD2). Gene therapy has become a promising strategy to inhibit the degradation of HIF-1α and to improve cardiac function after ischemic injury. However, conventional gene delivery systems are difficult to achieve a targeted and localized gene delivery into the ischemic myocardia. Here, we report the localized myocardial delivery of shRNA against PHD2 through ultrasound-targeted microbubble destruction (UTMD) for protection the heart from acute myocardial infarction. In this study, a novel cationic microbubble was fabricated by using of the thin-film hydration and sonication method. The resulting microbubbles had a 28.2 ± 2.21 mV surface zeta potential and could greatly improve DNA binding performance, achieving 17.81 ± 1.46 μg of DNA loading capacity per 5 × 108 microbubbles. Combined with these cationic microbubbles, UTMD-mediated gene delivery was evaluated and the gene transfection efficiency was optimized in the H9C2 cardiac cells. Knockdown of PHD2 gene was successfully realized by UTMD-mediated shPHD2 transfection, resulting in HIF-1α-dependent protective effects on H9C2 cells through increasing the expression of HIF-1α, VEGF and bFGF. We further employed UTMD-mediated shPHD2 transfection into the localized ischemic myocardia in a rat ischemia model, demonstrating significantly reduced infarct size and greatly improved the heart function. The silencing of PHD2 and the up-regulation of its downstream genes in the treated myocardia were confirmed. Histological analysis further revealed numbers of HIF-1α- and VEGF-, and CD31-positive cells/mm2 in the shPHD2-treated group were significantly greater than those in the sham or control vector groups (P < 0.05). In conclusion, our study provides a promising strategy to realize ultrasound-mediated localized myocardial shRNA delivery to protect the heart from acute myocardial infarction via cationic microbubbles.
登录
查看更多内容
影响因子:
5.2
作者:
Gandia, Carolina;Arminan, Ana;Sepulveda, Pilar
通讯作者:
Sepulveda, Pilar
影响因子:
10.8
作者:
Otani, Kentaro;Yamahara, Kenichi;Nagaya, Noritoshi
通讯作者:
Nagaya, Noritoshi
影响因子:
9.7
作者:
Nomikou, Nikolitsa;Tiwari, Poonam;McHale, Anthony P.
通讯作者:
McHale, Anthony P.
影响因子:
24
作者:
Kobulnik, Jeremy;Kuliszewski, Michael A.;Leong-Poi, Howard
通讯作者:
Leong-Poi, Howard
影响因子:
9.3
作者:
Lu J;Yao YY;Dai QM;Ma GS;Zhang SF;Cao L;Ren LQ;Liu NF
通讯作者:
Liu NF